Risk of Acquiring Blood-Borne Viruses by Treatment
| Type of Concentrates . | No Viral Markers . | Positive for TTV Only . | Positive for any of the Viral Markers Tested . | ||||
|---|---|---|---|---|---|---|---|
| No. of Patients . | No. of Patients . | Odds Ratio . | (95% CI) . | No. of Patients . | Odds Ratio . | (95% CI) . | |
| Virus-inactivated | 11 | 16 | # | 6 | # | ||
| Recombinant | 16 | 2 | 0.09 | (0.01-0.52) | 0 | 0 | (0-0.82) |
| Unmodified | 5 | 9 | 1.24 | (0.27-5.79) | 113 | 41.4 | (9.3-204.5) |
| Type of Concentrates . | No Viral Markers . | Positive for TTV Only . | Positive for any of the Viral Markers Tested . | ||||
|---|---|---|---|---|---|---|---|
| No. of Patients . | No. of Patients . | Odds Ratio . | (95% CI) . | No. of Patients . | Odds Ratio . | (95% CI) . | |
| Virus-inactivated | 11 | 16 | # | 6 | # | ||
| Recombinant | 16 | 2 | 0.09 | (0.01-0.52) | 0 | 0 | (0-0.82) |
| Unmodified | 5 | 9 | 1.24 | (0.27-5.79) | 113 | 41.4 | (9.3-204.5) |